Stock NKTR NEKTAR THERAPEUTICS
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Nektar Therapeutics

Equities

NKTR

US6402681083

Market Closed - Nasdaq
Other stock markets
 21:00:00 28/06/2024 BST 		5-day change 1st Jan Change
1.24 USD +8.77% Intraday chart for Nektar Therapeutics +6.90% +119.47%
06-10 Transcript : Nektar Therapeutics Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 02:00 PM
05-09 Earnings Flash (NKTR) NEKTAR THERAPEUTICS Reports Q1 Revenue $21.6M, vs. Street Est of $15.3M MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
NEKTAR THERAPEUTICS Stock Nektar Therapeutics
 228M -
ELI LILLY AND COMPANY Stock Eli Lilly and Company
 815B
JOHNSON & JOHNSON Stock Johnson & Johnson
 352B - - - -
MERCK & CO., INC. Stock Merck & Co., Inc.
 314B
ABBVIE INC. Stock AbbVie Inc.
 303B
ASTRAZENECA PLC Stock AstraZeneca PLC
 242B
  1. Stock Market
  2. Equities
  3. NKTR Stock
  4. Charts Nektar Therapeutics
  5. Sector Chart